MAPK8 and rheumatoid arthritis: Pretreatment of RA SF cells with either of the specific inhibitors SB202190, PD98059, or SP600125, significantly (*P < 0.05 vs IL) inhibited phosphorylation of p38, Erk, and JNK, respectively.